Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeStance Health Group, Inc.LFST · Entity 3936 | Chief Operating Officer | August 10, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeStance Health Group, Inc.
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 281,289 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Sale · Disposed 47,912 · Balance 281,289 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 12, 2026 20:59 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 47,912 | $10.85 | $519,845.20 |
DisclosureSEC source: 0001193125-26-347084 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 281,289 Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 23:02 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 13,446 | $6.91 | $92,911.86 |
DisclosureSEC source: 0001193125-26-102651 · ownership.xml · nonDerivative · entry 3 Miller Lisa K · CIK 0002036749 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,201 F3 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 23:02 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 26,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-102651 · ownership.xml · nonDerivative · entry 2 Miller Lisa K · CIK 0002036749 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,647 F2 · shares: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 23:02 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 14,766 | $6.91 | $102,033.06 |
DisclosureSEC source: 0001193125-26-102651 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,811 F1 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 00:09 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 21,590 | $6.93 | $149,618.70 |
DisclosureSEC source: 0001193125-26-099056 · ownership.xml · nonDerivative · entry 2 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,577 F2 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 00:09 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 107,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-099056 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,167 F1 · shares: Includes 107,914 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:25 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 57,240 | $6.43 | $368,053.20 |
DisclosureSEC source: 0001193125-25-297294 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,292 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.41 to $6.50 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 10, 2025 Filed Nov 13, 2025 22:53 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 10,623 | $6.43 | $68,305.89 |
DisclosureSEC source: 0001193125-25-280594 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,532 F1 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on November 10, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 23:29 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 18,845 | $6.90 | $130,030.50 |
DisclosureSEC source: 0000950170-25-041594 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,810 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.89 to $6.91 inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 10, 2025 Filed May 20, 2025 00:49 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 10,655 | $7.11 | $75,757.05 |
DisclosureSEC source: 0000950170-25-074780 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,155 F1 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 10, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 6,431 | $7.88 | $50,676.28 |
DisclosureSEC source: 0000950170-25-036739 · ownership.xml · nonDerivative · entry 2 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 358,655 F2 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 76,142 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036739 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,086 F1 · shares: Includes 76,142 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 10,540 | $7.45 | $78,523.00 |
DisclosureSEC source: 0000950170-24-127619 · ownership.xml · nonDerivative · entry 1 Miller Lisa K · CIK 0002036749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,994 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.